Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Transplant Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01808456
What this trial is testing

Standard-dose Versus High-dose Flu Vaccine in Solid Organ Transplant.

Who this might be right for
Influenza, HumanTransplantation Infection
Inova Health Care Services 62
Testing effectiveness (Phase 2)Study completedNCT05518487
What this trial is testing

COVID Protection After Transplant - Sanofi GSK (CPAT-SG) Study

Who this might be right for
COVID-19Kidney Transplant
National Institute of Allergy and Infectious Diseases (NIAID) 15
Post-approval studies (Phase 4)UnknownNCT05799716
What this trial is testing

Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections

Who this might be right for
ViremiaBacteremiaAcute Rejection of Renal Transplant
Shanghai Changzheng Hospital 40
Not applicableStudy completedNCT01090232
What this trial is testing

Host Responses in Kidney-transplant Recipients With Chronic Hepatitis E Virus Infection

Who this might be right for
Kidney-transplant Recipients With Chronic Hepatitis E Virus Infection
Assistance Publique Hopitaux De Marseille 17
Post-approval studies (Phase 4)Study completedNCT01298102
What this trial is testing

Influenza A/H1N1/2009-adjuvanted Vaccine in Renal Disease Patients

Who this might be right for
Decreased Immunologic Activity [PE]InfluenzaRejection
Erasme University Hospital 185
Large-scale testing (Phase 3)Study completedNCT00045292
What this trial is testing

Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Not applicableEnded earlyNCT00957736
What this trial is testing

Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 252
Testing effectiveness (Phase 2)Study completedNCT01756508
What this trial is testing

Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury

Who this might be right for
End-Stage Renal DiseaseKidney FailureGraft Reperfusion Injury
Russian Academy of Medical Sciences 57
Testing effectiveness (Phase 2)UnknownNCT00828503
What this trial is testing

Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients

Who this might be right for
Cytomegalovirus Disease
Marcus Saemann 40
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Not applicableStudy completedNCT07784452
What this trial is testing

Comparing Hepatitis B Vaccination Schedules in Patients on Hemodialysis

Who this might be right for
Hepatitis BESRD (End Stage Renal Disease)Kidney Failure+1 more
Jinnah Hospital 104
Large-scale testing (Phase 3)Study completedNCT02692703
What this trial is testing

Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2)

Who this might be right for
Chronic Hepatitis CHCVHepatitis C Virus
AbbVie 100
Testing effectiveness (Phase 2)Study completedNCT01685372
What this trial is testing

Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults

Who this might be right for
Solid Organ Transplant Recipient (Liver, Kidney, Heart)Rheumatologic DisorderHuman Immunodeficiency Virus (HIV)+2 more
University of Colorado, Denver 16
Not applicableStudy completedNCT03631316
What this trial is testing

Pharmacokinetic Parameters of Innovative Valganciclovir Versus Generic Valganciclovir

Who this might be right for
Kidney TransplantationCytomegalovirus InfectionsPharmacokinetics+1 more
Luis Eduardo Morales Buenrostro 8
Large-scale testing (Phase 3)UnknownNCT02729116
What this trial is testing

Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients

Who this might be right for
Anti-Infective Agents, UrinaryEscherichia Coli InfectionsKlebsiella Infections+2 more
Khon Kaen University 30
Not applicableUnknownNCT05727709
What this trial is testing

Dynamic Changes of Torquetenovirus (TTV) Load in Chinese Renal Transplant Recipients

Who this might be right for
Kidney Transplant RejectionKidney Transplant InfectionVirus+1 more
Tongji Hospital 220
Not applicableStudy completedNCT04333602
What this trial is testing

Asymptomatic Bacteriuria in Early Kidney Transplantation Follow up

Who this might be right for
Asymptomatic BacteriuriaKidney Transplant Infection
Centenario Hospital Miguel Hidalgo 80
Not applicableStudy completedNCT00805571
What this trial is testing

Urinary Kidney Injury Molecule-1 (KIM-1) Excretion As Biomarker for Injury in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Dysfunction
Northwell Health 120
Testing effectiveness (Phase 2)Study completedNCT01136395
What this trial is testing

Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation

Who this might be right for
Kidney TransplantationRituximab (RTx)Living Donors+2 more
University of Giessen 85
Not applicableStudy completedNCT03880682
What this trial is testing

Direct Acting Antivirals for HCV Infection in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant; ComplicationsHepatitis C, Chronic
Istanbul University 30
Next Page